BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

CepTor Corporation 

200 International Circle, Suite 5100

Hunt Valley  Maryland  21030  U.S.A.
Phone: 410-527-9998 Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Research





 Company News
CepTor Corporation (CEPO.OB) Reports Significant Reduction Of Multiple Sclerosis (MS) Symptoms With Oral Delivery Of Neurodur In EAE Model 10/12/2006 11:34:42 AM    More...
CepTor Corporation (CEPO.OB) Reports Two Issues Remain To Move Myodur IND Forward 10/9/2006 12:04:42 PM    More...
CepTor Corporation (CEPO.OB) Executes LOI With Ferring For Late Stage Product; Superoxide Dismutase Targeted For Phase 2B Clinical Trials 9/15/2006 9:57:37 AM    More...
CepTor Corporation (CEPO.OB) Seeks Approval To Initiate Clinical Trial Of Myodur For Muscular Dystrophy; Submits IND Complete Response To FDA 9/12/2006 10:08:43 AM    More...
CepTor Corporation (CEPO.OB) Retains Oppenheimer & Co. To Enhance Shareholder Value 5/3/2006 1:06:14 PM    More...
CepTor Corporation (CEPO.OB) Presents Statistically Significant Proof Of Concept Data On Myodur For Muscular Dystrophy At The American Academy Of NeurologyMeeting 4/25/2006 1:18:36 PM    More...
CepTor Corporation (CEPO.OB) Adopts Shareholder Rights Plan 3/9/2006 11:01:07 AM    More...
CepTor Corporation (CEPO.OB) Retains Banyan Biomarkers To Develop Test To Evaluate Effectiveness Of Myodur For Muscular Dystrophy 2/7/2006 1:29:28 PM    More...
CepTor Corporation (CEPO.OB) Receives Dual Orphan Drug Designation For Myodur (C101) For Duchenne And Becker Muscular Dystrophies 1/25/2006 1:14:19 PM    More...
CepTor Corporation (CEPO.OB) Submits Investigational New Drug Application (IND) To Initiate Clinical Trials With Myodur (C-101) In Duchenne Muscular Dystrophy (DMD) Patients 1/17/2006 12:03:16 PM    More...
12345

//-->